NeuroQuest Inc., Halifax, Canada, is a drug development company seeking new approaches to modulation of nerve transmission and promising clinical applications particularly for neuropathic pain. The company focuses on a first-in-class small molecule drug discovery platform which is based on bioactives discovered in plant extracts showing efficacy for neuropathic pain. This is an unusually novel and promising opportunity which focuses on the development of a novel class of analgesics.
Contact information
1411 Oxford Street
Halifax, Nova Scotia
Canada B3H 3Z1
- 902.444.8696 - Phone
- 902.444.4655 – Fax
- Robert Cervelli – CEO- cervelli@neuroquest.ca
Return to Members Directory
